REACTIVE TRHOMBOCYTOSIS IN CHILDREN

Ayu Hafsari, Nadirah Rasyid Ridha

Abstract


Thrombocytosis is a condition which the platelet count exceeds 450,000/mm3. Thrombocytosis was classified as: mild (450,000-700,000/mm3), moderate (700,000-900,000/mm3), severe (900,000-1,000,000/mm3) and extreme (>1,000,000/mm3). Functionally, thrombocytosis is divided into primary (essential) and secondary (reactive). The novelty of this study due to examining reactive thrombocytosis in children. The purpose of this study was to look at reactive thrombocytosis in children.  Essential thrombocytosis is a myeloproliferative disorder due to monoclonal or polyclonal abnormalities of hematopoietic cells or biologic abnormalities of thrombopoietin (Tpo) in the primary regulation of megakaryopoiesis. Meanwhile, reactive thrombocytosis occurs temporarily due to stimulation of megakaryopoiesis with haematological or non-haematological abnormalities. Reactive thrombocytosis is an increase in thrombopoiesis due to reactive process due to infection, chronic inflammation, malignancy, and splenectomy surgery. Bacterial or viral infections are the most common cause (about 37-78%) at any age during childhood. Reactive thrombocytosis are asymptomatic and is usually found incidentally. Based on the guidelines the British Society for Haematology recommends three initial investigations: (1) Peripheral blood smear, (2) Inflammatory markers, and (3) Iron status. Management of reactive thrombocytosis by threated the main diseases, then platelet count returns to normal after the underlying disease is resolved. The overall prognosis depends on the underlying causative condition, approximately 8% of patients with acute infection examined have mild, transient thrombocytosis and show no infectious complications. However, these patients had an increased acute-phase response, prolonged length of stay, more bacteraemia and increased mortality although it only affected a minority of patients. This distinction between essential and reactive thrombocytosis is important because it implies evaluation, prognosis and treatment.

Keywords: Reactive Thrombocytosis; Secondary Thrombocytosis; Transient.

Keywords


Reactive Thrombocytosis; Secondary Thrombocytosis; Transient.

Full Text:

PDF

References


Holinstat, M. Normal platelet function. Cancer and Metastasis Reviews. 2017;

Lubis. B. Trombositosis. Buku Ajar Hematologi Onkologi Anak. Edisi Revisi. Jakarta: Hal: 183-7. 2018;

Aswad Y. Darah Pendierita Hipertensi Di Panti Wirda Ilomata Effect of Considered Imagination on Blood Pressure Hypertension Patients at Wirda Ilomata retirement home. 2019;1(1):7–12.

Rokkam VR KR. Secondary Thrombocytosis. [Updated 2021 Aug 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. 2022;

Kaufman RM AK. Abnormalities of Platelets and Platelet Support. In: Kufe DW, Pollock RE, Weichselbaum RR, et al., editors. Holland-Frei Cancer Medicine. 6th edition. Hamilton (ON): BC Decker; 2003. Available from: https://www.ncbi.nlm.nih.gov/books/NBK12971/. 2003;

Kucine N, Chastain KM, Mahler MB BJ. Primary thrombocytosis in children. Haematologica. 2014;99(4):620-628. doi:10.3324/haematol.2013.092684. 2014;

Thakral, B., Wang, S.A. Thrombocytosis, in: Diagnosis of Blood and Bone Marrow Disorders. Springer International Publishing, pp. 225–242. 2018;

Arbi. F. Gangguan Fungsi Trombosit. Buku Ajar Hematologi Onkologi Anak. Edisi Revisi. Jakarta: 2018. Hal: 173-5. 2018.

Ghoshal, K., Bhattacharyya, M. Overview of platelet physiology: Its hemostatic and nonhemostatic role in disease pathogenesis. The Scientific World Journal. 2014;

Lefrançais, E., Looney, M.R. Platelet biogenesis in the lung circulation. Physiology. 2019;

Patel SR, Hartwig JH IJJ. The biogenesis of platelets from megakaryocyte Mathur, A., Samaranayake, S., Storrar, N.P.F., Vickers, M.A., 2019. The BMJ 366. 2019;

Tallitsch RB, Frederic M MJT. Human anatomy(5th ed.). San Francisco: Pearson/Benjamin Cummings. p. 529. ISBN 978-0-8053-7211-3.

White JG. Disorders Affecting Megakaryocytes and Platelets. Inherited Conditions. Second Edition. Elsevier Ltd; 2011. doi:10.1016/B978-0-7020-3147-2.00032-8. 2011;

van der Meijden, P.E.J., Heemskerk, J.W.M. Platelet biology and functions: new concepts and clinical perspectives. Nature Reviews Cardiology. 2019;

Stockklausner C, Duffert CM, Cario H, Knöfler R, Streif W KA. Thrombocytosis in children and adolescents—classification, diagnostic approach, and clinical management. Ann Hematol. 2021;100(7):1647-1665. 2021;

Bleeker, J.S., Hogan, W.J. Thrombosis 2011, 1–16. 2011.

Jaishankar D SP. Secondary Thrombocytosis [internet]. Medsape. 2020. [Cited 19th March 2022]. Available from https://emedicine.medscape.com/article/206811-overview#a2. 2022;

Mantadakis, E., Tsalkidis, A., & Chatzimichael A. Thrombocytosis in childhood. Indian pediatrics, 45(8), 669–677. 2008.

Dame, C., Sutor, A.H. Primary and secondary thrombocytosis in childhood. British Journal of Haematology. 2005;

Scharf, R.E. Do we need antiplatelet therapy in thrombocytosis? Contra: Proposal for an individualized risk-adapted treatment. Hamostaseologie. 2016;

Ang A AA. Pathogenesis of Thrombocytosis. The Calgary Guide to Understanding Disease. [Internet]. Calgaryguide. 2013. [Cited 19th March 2022]. Available from https://calgaryguide.ucalgary.ca/pathogenesis-of-thrombocytosis/. 2022;

Inoue S. Pediatric Thrombocytosis [internet]. Medscape. [Cited 19th March 2022]. Available from https://emedicine.medscape.com/article/206811-overview. 2020;

Chen, Y., Zhong, H., Zhao, Y., Luo, X., Gao, W. Role of platelet biomarkers in inflammatory response. Biomarker Research. 2020;

Kaushansky, K. The molecular mechanisms that control thrombopoiesis. Journal of Clinical Investigation. 2005;

Evstatiev, R., Bukaty, A., Jimenez, K., Kulnigg-Dabsch, S., Surman, L., Schmid, W., Eferl, R., Lippert, K., Scheiber-Mojdehkar, B., Michael Kvasnicka, H., Khare, V., Gasche, C. American Journal of Hematology 89, 524–529. 2014.

Akkermans, M.D., Uijterschout, L., Vloemans, J., Teunisse, P.P., Hudig, F., Bubbers, S., Verbruggen, S., Veldhorst, M., de Leeuw, T.G., van Goudoever, J.B., Brus, F. Pediatric Hematology and Oncology 32, 624–632. 2015.

Khan, P., Nair, R., Olivares, J., Tingle, L., Li, Z. Baylor University Medical Center Proceedings 22, 294–294. 2009;

Sarangi R, Pradhan S, Dhanawat A, Patanayak R BG. Thrombocytosis in children: Clinico-hematological profile from a single centre in Eastern India. J Lab Physicians. 2018;10(01):034-037. doi:10.4103/jlp.jlp_90_17. 2018;

Mathur, A., Samaranayake, S., Storrar, N.P.F., Vickers, M.A. The BMJ 366. 2019;

Gunawan.S. Intepretasi Darah Tepi. Buku Ajar Hematologi Onkologi Anak. Edisi Revisi. Jakarta: 2018. Hal: 439-40. 2018;

Appleby. N. Clinical and laboratory assessment of a patient with thrombocytosis. British Journal of Hospital Medicine 2017 78:10, 558-564. 2017;




DOI: https://doi.org/10.37905/ijhsmr.v1i2.14134

Refbacks

  • There are currently no refbacks.